Renal Medullary Carcinoma: Case Report of an Aggressive Malignancy with Near-Complete Response to Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Chemotherapy

Table 1

Case reports of complete radiological responses, regimens used, and survival of patients with renal medullary carcinoma.

Case report	Regimen described	Survival
Stahlschmidt et al. (1999) [9]	MVAC	11.2 months
Simpson et al. (2005) [10]	MVAC	11.2 months
Strouse et al. (2005) [11]	Cisplatin, gemcitabine, and paclitaxel	10 months and 11 months
Ronnen et al. (2006) [12]	Bortezomib	Alive with no evidence of disease at 27 months
Walsh et al. (2010) [13]	Carboplatin, gemcitabine, and paclitaxel	24 months